CORIFOLLITROPIN ALFA: 46 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
46
Total FAERS Reports
0
Deaths Reported
27
Hospitalizations
46
As Primary/Secondary Suspect
1
Disabilities
First Report: 20110907 · Latest Report: 20250326
What Are the Most Common CORIFOLLITROPIN ALFA Side Effects?
#1 Most Reported
Ovarian hyperstimulation syndrome
18 reports (39.1%)
#2 Most Reported
Ascites
13 reports (28.3%)
#3 Most Reported
Generalised tonic-clonic seizure
11 reports (23.9%)
All CORIFOLLITROPIN ALFA Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Ovarian hyperstimulation syndrome | 18 | 39.1% | 0 | 18 |
| Ascites | 13 | 28.3% | 0 | 13 |
| Blood oestrogen increased | 11 | 23.9% | 0 | 0 |
| Condition aggravated | 11 | 23.9% | 0 | 0 |
| Generalised tonic-clonic seizure | 11 | 23.9% | 0 | 0 |
| Drug interaction | 10 | 21.7% | 0 | 0 |
| Drug level decreased | 10 | 21.7% | 0 | 0 |
| Drug ineffective | 8 | 17.4% | 0 | 0 |
| Pain | 8 | 17.4% | 0 | 8 |
| Dyspnoea | 7 | 15.2% | 0 | 6 |
Who Reports CORIFOLLITROPIN ALFA Side Effects? Age & Gender Data
Gender: 100.0% female, 0.0% male. Average age: 35.4 years. Most reports from: DE. View detailed demographics →
Is CORIFOLLITROPIN ALFA Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2011 | 1 | 0 | 1 |
| 2012 | 11 | 0 | 0 |
| 2014 | 4 | 0 | 4 |
| 2017 | 4 | 0 | 2 |
| 2018 | 4 | 0 | 4 |
| 2019 | 3 | 0 | 0 |
| 2020 | 1 | 0 | 0 |
| 2021 | 4 | 0 | 4 |
| 2022 | 1 | 0 | 0 |
| 2023 | 3 | 0 | 3 |
| 2024 | 2 | 0 | 2 |
| 2025 | 5 | 0 | 5 |
What Is CORIFOLLITROPIN ALFA Used For?
| Indication | Reports |
|---|---|
| Controlled ovarian stimulation | 16 |
| Assisted reproductive technology | 9 |
| Ovulation induction | 5 |
Official FDA Label for CORIFOLLITROPIN ALFA
Official prescribing information from the FDA-approved drug label.